BG Medicine Announces Decision to Withdraw IPO.WALTHAM, Mass. -- BG Medicine, a medical diagnostics company, announced today that based on current market conditions, it has chosen not to proceed with its planned initial public offering at this time. The company has withdrawn its registration statement on Form S-1 as filed with the Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of such common shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. About BG Medicine BG Medicine is a life sciences company focused on the discovery, development and commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. BG Medicine discovers biomarkers and develops its diagnostic product candidates using its proprietary, versatile, and scalable technology platform which integrates and automates the precise measurement, analysis, characterization and interpretation of thousands of proteins, metabolites Metabolites Substances produced by metabolism or by a metabolic process. Mentioned in: Interactions and nucleic acids Nucleic acids The cellular molecules DNA and RNA that act as coded instructions for the production of proteins and are copied for transmission of inherited traits. collected from bodily fluids Noun 1. bodily fluid - the liquid parts of the body body fluid, liquid body substance, humour, humor body substance - the substance of the body aqueous humor, aqueous humour - the limpid fluid within the eyeball between the cornea and the lens . This approach to biomarker discovery Biomarker discovery is the process by which biomarkers are discovered. It is a medical term. Many commonly used blood tests in medicine are biomarkers. The way that these tests have been found can be seen as biomarker discovery. allows BG Medicine to pursue the most promising commercial opportunities because it is not constrained con·strain tr.v. con·strained, con·strain·ing, con·strains 1. To compel by physical, moral, or circumstantial force; oblige: felt constrained to object. See Synonyms at force. 2. by biology or specimen type. BG Medicine is leveraging its technology platform in multiple biomarker biomarker /bio·mark·er/ (bi´o-mahr?ker) 1. a biological molecule used as a marker for a substance or process of interest. 2. tumor marker. bi·o·mark·er n. 1. initiatives and collaborations with major pharmaceutical companies, other healthcare organizations and the U.S. Food and Drug Administration. For additional information about BG Medicine, please visit http://www.bg-medicine.com. |
|
|||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion